Elevate Rises Above With 2023 MM+M Award Nominations

Elevate Scores with Multiple Nominations at the MM+M Awards 20th Anniversary

Elevate has been raising the bar for healthcare marketing for eight years as a leading healthcare agency. Once again, Elevate and several of its campaigns are being recognized as some of the best in the industry by MM+M, the premier publication in healthcare marketing. The annual MM+M Awards, now in its 20^th year, recognize, champion, and celebrate the most creative and effective campaigns in healthcare, showcasing creative initiatives that are “elevating” healthcare marketing. More than 90 judges boasting a wide range of expertise narrowed down the hundreds of entries to a select few. This rigorous analysis has made the MM+M Awards the industry’s gold standard. This year, Elevate has been nominated in three major categories. The first is Best Branded Website for Healthcare Professionals (Stop Flares Fast, TOBRADEX ST), the second is Best Professional Print Campaign (See More. Resect More. Gleolan), and the third nomination is for Elevate as Rare Disease Agency of the Year.

Nominated for Best Branded Website for Healthcare Professionals, the Stop Flares Fast (TOBRADEX ST) campaign uses the arresting visual of eyelashes as burnt, flaming matchsticks to highlight the brand’s effectiveness at stopping the cycle of inflammation and infection common in blepharitis/meibomian gland dysfunction (MGD). Physicians can imagine the need to have the inflammation extinguished by TOBRADEX ST.

The nomination for Gleolan (aminolevulinic acid HCl) as Best Professional Print campaign is no surprise, as the campaign for the innovative optical imaging agent—the first and only FDA-approved agent for use during fluorescence-guided surgery (FGS) indicated in patients with glioma as an adjunct for the visualization of malignant tissue during surgery—has received an incredible amount of recognition for its bold visual and compelling call to action to Illuminate with Gleolan to See More. The arresting imagery of a “tumor monster” hiding in the margins, being illuminated by Gleolan, has been an effective and memorable tool for the brand.

One that is particularly exciting is the nomination for Rare Disease Agency of the Year. After three consecutive years as MM+M Small Agency of the Year, Elevate is proud to be nominated for this prestigious designation. The agency partners with multiple rare disease brands, including NORD, the leading rare disease organization in the US, serving the almost 30,000 people living with rare diseases.

Elevate continues to be the champion of healthcare challenger brands by helping them reach their full potential, an approach that has once again led to being honored as one of the top agencies in healthcare marketing.  Most of all, these key nominations represent evidence of successful achievements on behalf of their client partners.

See the full list of agency nominations at MM+M.